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Improved Left Ventricular Mass Quantification With Partial 
Voxel Interpolation
In Vivo and Necropsy Validation of a Novel Cardiac MRI 
Segmentation Algorithm
Noel C.F. Codella, PhD; Hae Yeoun Lee, PhD; David S. Fieno, MD. PhD; Debbie W. Chen, BA;
Sandra Hurtado-Rua, PhD; Minisha Kochar, MD; John Paul Finn, MD; Robert Judd, PhD;
Parag Goyal, MD; Jesse Schenendorf, BA; Matthew D. Cham, MD; Richard B. Devereux, MD; 
Martin Prince, MD, PhD; Yi Wang, PhD; Jonathan W. Weinsaft, MD
Background—Cardiac magnetic resonance (CMR) typically quantifies LV mass (LVM) by means of manual planimetry 
(MP), but this approach is time-consuming and does not account for partial voxel components— myocardium admixed 
with blood in a single voxel. Automated segmentation (AS) can account for partial voxels, but this has not been used 
for LVM quantification. This study used automated CMR segmentation to test the influence of partial voxels on 
quantification of LVM.
Methods and Results—LVM was quantified by AS and MP in 126 consecutive patients and 10 laboratory animals 
undergoing CMR. AS yielded both partial voxel (ASpv) and full voxel (ASfv) measurements. Methods were 
independently compared with LVM quantified on echocardiography (echo) and an ex vivo standard of LVM at 
necropsy. AS quantified LVM in all patients, yielding a 12-fold decrease in processing time versus MP (0:21 ±0:04 
versus 4:18±l:02 minutes; P<0.00T). ASFV mass (136±35 g) was slightly lower than MP (139±35; Δ = 3±9 g, 
P<0.001). Both methods yielded similar proportions of patients with LV remodeling (P=0.73) and hypertrophy 
(P=1.00). Regarding partial voxel segmentation, ASpv yielded higher LVM (159±38 g) than MP (Δ=20±10 g) 
and ASfv (Δ=23±6 g, both P<0.00T), corresponding to relative increases of 14% and 17%. In multivariable 
analysis, magnitude of difference between ASpv and ASfv correlated with larger voxel size (partial r=0.37, 
P<0.001) even after controlling for LV chamber volume (r=0.28, P=0.002) and total LVM (r=0.19, P=0.03). 
Among patients, ASpv yielded better agreement with echo (Δ = 20±25 g) than did ASfv (Δ=43±24 g) or MP 
(Δ = 40±22 g, both P<0.001). Among laboratory animals, ASpv and ex vivo results were similar (∆=l±3 g, 
P=0.3), whereas ASfv (6±3 g, P<0.001) and MP (4±5 g, P=0.02) yielded small but significant differences with 
LVM at necropsy.
Conclusions—Automated segmentation of myocardial partial voxels yields a 14-17% increase in LVM versus full voxel 
segmentation, with increased differences correlated with lower spatial resolution. Partial voxel segmentation yields 
improved CMR agreement with echo and necropsy-verified LVM. (Circ Cardiovasc Imaging. 2012;5:137-146.)
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Left ventricular mass (LVM) is widely used to guide clinical decision-making and prognostic assessment.1·2 
Cardiac magnetic resonance (CMR) is well suited to assess 
LVM because it provides high-resolution tomographic imag­
ing that enables volumetric quantification without geometric 
assumptions. LVM quantification on CMR is typically done 
using manual planimetry (MP), whereby myocardial borders
are traced by hand. Although MP has the potential to be 
highly detailed, it can be time-consuming, especially when 
LV chamber dilation is present.3 MP can be especially 
challenging with respect to LV trabeculations, which contrib­
ute to LVM but are irregular in shape and can be difficult to 
discern from LV blood pool. Although MP of trabeculae has 
been reported to decrease CMR reproducibility and prolong
MP processing time,4,5 failure to account for trabeculae yields 
increased discordance with necropsy-verified LVM and alters 
clinical classifications for patients with LV remodeling, in 
whom trabecular size and complexity are increased.6-8
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Automated segmentation (AS) can rapidly quantify highly 
detailed structures within the heart and elsewhere. Recent AS 
advances have enabled quantification of partial voxels— 
discrete structures admixed within a single imaging voxel. 
This approach fundamentally differs from conventional (full 
voxel) analysis, whereby regions are partitioned in a binary 
manner, based on location in relation to manual or automated 
contours. Though new to CMR, partial voxel segmentation 
has been successfully applied to other organs: Neurological 
studies have shown this to be useful for segmentation of 
tissue borders and irregularly contoured structures.9-12 By 
extension, partial voxel segmentation holds particular rele­
vance for LVM as it can account for endocardial irregularities 
and LV trabeculae.
AS algorithms have recently been developed that can 
simultaneously perform full and partial voxel segmentation of 
routine cine-CMR (steady-state free precession [SSFP]) im­
ages.13·14 Instead of generating shape-based contours that 
mimic MP, the algorithms measure statistics regarding signal 
intensities of blood and myocardium, and, from this, perform 
voxel-by-voxel segmentation whereby partial voxel content 
of each substance is quantified for every LV voxel. In an 
initial validation study, partial voxel segmentation closely 
agreed with ex vivo phantom volumes and was applied in 
vivo for LV chamber quantification.13 However, to date, 
partial voxel segmentation has not been used to measure 
LVM.
This study tested LVM segmentation among clinical pa­
tients and laboratory animals undergoing CMR. In patients, 
echocardiography (echo) was performed within 1 day of 
CMR and used as a clinical comparator for LVM. In 
laboratory animals, euthanasia was performed after CMR and 
segmentation results were compared with ex vivo LV weight. 
The aim was to examine the impact of partial voxel segmen­
tation on CMR quantification of LVM.
Methods
Clinical Protocol
The study sample comprised consecutive patients enrolled in a 
post-myocardial infarction (MI) registry who underwent CMR and 
echo within a 1-day interval.15 Imaging was performed between 
September 2006 and April 2010 at Weill Cornell Medical College. 
The study was conducted in accordance with the Weill Cornell 
Institutional Review Board; written informed consent was obtained 
at study enrollment.
CMR Image Acquisition
CMR was performed at 1.5 T (General Electric), using a standard 
2-dimensional SSFP pulse sequence. Short-axis SSFP images were 
acquired from the mitral annulus through the LV apex. Typical SSFP 
parameters were repetition time, 3.5 ms; echo time, 1.6 ms; flip 
angle, 60°; temporal resolution, 30-50 ms; and in-plane spatial 
resolution, 1.6× 1.3 mm. Images were acquired with a slice thickness
of 6.0 mm and interslice gap of 4.0 mm. CMR imaging was 
performed without adjunctive contrast (gadolinium) administration.
LVM Quantification
LVM was quantified on CMR, using MP and AS. AS segmentation 
was performed with simultaneous calculation of LVM based on full 
(ASFV) and partial (ASpv) voxel calculated myocardial content.
AS and MP were performed independently, blinded to results of 
the other method. For each, contiguous end-diastolic short-axis 
images were segmented from LV base through apex. Basal and 
apical images of all patient exams were defined in accordance with 
established clinical criteria,4·8 with the basal LV defined by the 
basal-most image encompassing at least 50% of circumferential 
myocardium. To directly compare AS with MP while minimizing 
potential confounding by slice and phase variance, basal-apical slice 
position and end-diastolic phase were held constant between meth­
ods. LVM was calculated as the product of myocardial specific 
gravity (1.05) and volume by each segmentation method.
Manual Planimetry
MP was performed in accordance with standard clinical practice, 
with LVM quantified by planimetry of end-diastolic endocardial and 
epicardial borders. Papillary muscles and trabeculae were included 
within myocardial contours; trabeculae were defined as myocardium 
protruding from the circumferential contour of the LV endocardium 
with similar signal intensity to the adjacent LV wall.4,8 Planimetry 
was performed using commercial software (ReportCARD 4.0, Gen­
eral Electric). MP was also used to quantify LV dimensions, 
volumes, and total endocardial surface area—defined as the area of 
planimetered endocardial surface for each slice, summed across all 
2D slices. Segmentation was performed by physicians (Drs Weinsaft 
and Cham) with American College of Cardiology/American Heart 
Association (ACC∕AHA)level III training in CMR.
Automated Segmentation
Automated LVM quantification was performed using integrated 
endocardial and epicardial segmentation, based on previously estab­
lished algorithms.13·14 User input included identification of slices to 
be segmented and definition of the mitral and aortic valve annuli.
For endocardium, segmentation was performed using a geometry- 
independent algorithm that quantifies the mixture of blood and 
myocardium in each LV pixel.13,14 Segmentation is accomplished by 
automatically computing blood and myocardial signal intensity 
distributions for each image individually (Figure 1A) and subse­
quently using that information to determine partial voxel content— 
defined as per voxel myocardial (or blood) content—for every voxel 
comprising the LV. The algorithm outputs 2 endocardial measure­
ments: (1) “partial voxel” analysis consisting of the sum of partial 
blood voxel contents of every voxel (ENDOpv) and (2) “full voxel” 
analysis consisting of the sum of all voxels with any fractional blood 
content (ENDOfv). Full voxel analysis closely mimics MP, which 
partitions myocardium and cavity in a binary manner, with trabec­
ulae included in LVM when contiguous in shape or of similar signal 
intensity to surrounding LV myocardium.4,7,8,16 Figures 1B and 1C 
provide an illustration of partial voxel content as quantified by the 
segmentation algorithm.
For epicardium, segmentation was performed using an active 
contour model that uses location and signal intensity infomration 
resulting from the endocardial segmentation, in addition to signal 
intensity and edges at the epicardial-pericardial interface.14 LVM 
was calculated on the basis of epicardial volume subtracted by either 
ENDOpv or ENDOFV, respectively.
Intraobserver and interobserver reproducibility of automated and 
manual CMR methods were tested among a random sample of 20 
patients.
Figure 1. Automated segmentation algorithm. A, Representative 
histogram generated by automated segmentation (AS). Solid 
blue line indicates myocardial mean signal intensity; dotted 
blue line, 2 SD above myocardial mean (all intensities below 
this threshold considered full myocardial voxels by AS). Solid 
green line indicates full-blood mean signal intensity; dotted 
green line, 2 SD below blood mean (all intensities above this 
threshold considered full-blood voxels). Blood and myocardial 
partial voxel content is linearly interpolated between dotted blue 
and dotted green lines. B, Endocardial voxel content and epi­
cardial contour as calculated by AS. Endocardial voxel content 
is displayed on a voxel-by-voxel basis, with colors mapped from 
blue to green, which represents 100% myocardium (0% blood) 
to 100% blood (0% myocardium), respectively. Epicardial con­
tour is displayed as a blue outline. C, Identical steady-state 
free precession image with all endocardial voxels containing 
100% blood removed from the display-only voxels containing 
less than 100% blood remain in the endocardial segmentation, 
and the epicardial contour is maintained as the outer outline.
Validation Protocol
Each method—MP, as well as ASfv and ASpv—was compared with 
2 standards for LVM, described as follows.
Clinical Validation: Echocardiography
Echocardiography was performed within 1 day of CMR in all 
patients. LVM was quantified in accordance with established con­
sensus guidelines17: Linear measurements on 2D and M-mode echo 
were used to calculate LVM using a standard formula 
(0.8*{ 1.04[(LVIDd+PWTd+SWTd)3_(LVIDd)3]} + 0.6 g), devel­
oped and validated on the basis of necropsy-verified LV weight.18-21 
Echo analysis was performed blinded to CMR data.
Two-dimensional and M-mode linear measurements by the des­
ignated ACC/AHA level Ill-certified echo reader for the current 
study (Dr Devereux) have been previously shown to be closely 
correlated to each other in a series of 196 adults (r=0.967, P<0.001, 
mean Δ=0.4 g, SD=10.2 g; P=NS).22 Among 22 participants in 
another study,23 LVM calculated from 2D linear measurements by 
the same reader (Dr Devereux) yielded values close to those obtained 
with use of M-mode recordings by a second reader (r=0.94, 
P<0.001; mean Δ=0.9 g, SD=9.5 g, P=NS). Excellent reproduc­
ibility between measurements by a single experienced reader from 
separate echocardiograms has previously been shown in a series of 
183 hypertensive adults for LVM (intraclass correlation coefficient 
[p] = 0.93, P<0.001, mean ∆=1.7 g, SD=18 g, P=NS) as well as 
LV chamber and wall dimensions (p=0.83-0.87), using echo 
methods applied in the current study.24
Table 1. Patient Characteristics
Age, y 57±13
Male sex 81% (102)
Atherosclerosis risk factors
Hypertension 44% (55)
Hyperlipidemia 48% (61)
Diabetes mellitus 20% (25)
Tobacco use 34% (43)
Family history 27% (34)
Coronary artery disease history
Prior myocardial infarction 6% (7)
Prior coronary revascularization 10% (12)
Cardiovascular medications
Beta-Blocker 98% (124)
ACE inhibitor/ARB 71% (89)
HMG-CoA reductase inhibitor 97% (122)
Aspirin 100% (126)
Thienopyridines 94% (119)
Myocardial infarct parameters
Infarct-related artery
Left anterior descending 63% (80)
Right coronary 29% (36)
Left circumflex 8% (10)
Infarct size, % myocardium 17±10
Post-myocardial infarction interval, d 26±8
LV chamber size and function
Cardiovascular magnetic resonance
Ejection fraction, % 51 ±11
End-diastolic volume, mL 154±44
End-systolic volume, mL 77 ±37
Echocardiography
Ejection fraction, % 48±11
End-diastolic diameter, cm 5.7±0.5
End-systolic diameter, cm 4.3±0.6
ACE indicates angiotensin-converting enzyme; ARB, angiotension II receptor 
blocker; LV, left ventricular.
Ex Vivo Validation: Necropsy
Necropsy validation of LVM was obtained in a preexisting cohort of 
animals that underwent CMR immediately before euthanasia, with 
confimration of LVM based on ex vivo weight.6·25 Necropsy speci­
mens were weighed within 30 minutes of animal euthanasia. Lor the 
current study, CMR images were retrieved from image archives, 
analyzed by MP and AS, and compared with necropsy-verified LV 
weight. To directly compare CMR methods with total LV weight at 
necropsy, segmentation of animal exams was performed with inclu­
sion of all slices containing LV myocardium. Basal-apical slice 
position and segmentation phases were matched between CMR 
methods.
Statistical Methods
Continuous variables (expressed as mean±SD) were compared using 
paired Student t test for 2-group comparisons. Categorical variables 
were compared using McNemar test for paired proportions. All 
continuous variables had qq plots and histograms suggesting nor­
mality. Processing time and LV volume were compared using 
bivariate correlation coefficients and linear mixed-effects models.
Multivariable linear regression analyses were used to evaluate 
associations between continuous variables.
Comparison of mean LVM by each quantification method was 
assessed using a linear mixed-effects model (taking into account the 
fact that echo, MP, ASfv, and ASpv measurements are correlated 
within patients/animals) with an unconstrained covariance matrix. 
Multiple comparisons procedures were used to control for family- 
wise error rate: For patient data, adjustment was done using the 
Tukey-Kramer multiple comparison procedure, which enabled pri­
mary comparison to the reference of echo as well as relative 
differences between CMR methods. For animal data, CMR methods 
were compared with necropsy reference with adjustment using the 
Dunett-Hsu multiple comparison procedure. Two-sided P<0.05 
indicated statistical significance. Calculations were performed using 
SPSS 12.0 (SPSS Inc, Chicago, IL) and SAS 9.2 (SAS Inc, Cary, NC).
Figure 2. Typical example. Typical short- 
axis images demonstrating automated 
segmentation (AS) (A) and manual planim­
etry (MP) (B) segmentation, both of which 
account for myocardial trabeculae and 
papillary muscles. In this example, left 
ventricular mass by ASfv (75.0 g∕m2) and 
MP (74.6 g∕m2) closely agreed, whereas 
ASpv yielded higher mass (86.4 g∕m2), 
respectively, corresponding to relative 
differences of 15% and 16% with ASfv 
and MP.
Results
Patient Sample
LVM segmentation was tested in 126 consecutive patients 
undergoing CMR as part of an ongoing study examining 
post-MI LV remodeling.15 No patients were excluded on the 
basis of clinical characteristics or image processing results. 
Table 1 details patient characteristics.
Automated LVM Segmentation
AS successfully quantified LVM in all cases. Of the total 
1127 images (126 exams, 8.9±0.9 images/examination), 51 
(4.5%) required endocardial corrections, 74 (6.6%) epicardial 
corrections, and 107 (9.5%) delineation of the basal LV 
outflow tract. In aggregate, 60% of exams required no manual 
adjustment apart from identification of LV images and 
truncation of the LV outflow tract. For the remainder, 
epicardial or endocardial contours were manually adjusted 
based on visual inspection (1.0 ±1.6 adjustments per exami­
nation, 58% epicardial). Endocardial or epicardial corrections 
were deemed necessary when automated segmentation failed 
to truncate the myocardial border with either LV cavity or 
pericardium (ie, due to temporal blurring and/or indistinct 
anatomic boundaries). Total processing time, including AS, 
visual inspection, and any manual adjustment, was under 1 
minute in all cases.
Figure 2 provides a typical example of LVM segmentation 
by AS compared with MP.
Table 2. Conventional LV Mass Segmentation: LV 
Segmentation Results
Manual
Planimetry
Automated 
Segmentation, 
Full Voxel Δ P
LV mass, g 139.1 ±35.1 135.9±35.0 3.1 ±9.3 g <0.001 ┼
LV mass 
index, g∕m2 
Diagnostic 
classifications*
71.1±15.1 69.5±15.3 1.6±4.7 g∕m2 <0.001 ┼
LV chamber 
remodeling
57% (72) 56% (70) 2% (2) 0.73
LV hypertrophy 3% (4) 4% (5) 1%(1) 1.00
LV indicates left ventricular.
*Based on previously established, population-based, cardiac magnetic 
resonance cutoffs.26,27
┼P value <0.05 (data presented as mean±SD).
Full Voxel Segmentation
Table 2 reports LVM quantification by ASfv and MP. LVM 
was slightly lower by ASfv, with average differences be­
tween methods (3±9 g, 1.6±4.7 g∕m2, P<0.001) correspond­
ing to 6±4% of LVM by MP. When established CMR-based 
cutoffs were applied,26·27 both methods yielded similar pro­
portions of patients meeting criteria for LV hypertrophy 
(P=1.00) and chamber remodeling (P=0.73).
Also shown in Figure 3A, processing time for AS was over 
12-fold lower versus MP (0:21 ±0:04 versus 4:18±1:02 
minutes), corresponding to an average time savings of nearly 
4 minutes (Δ=3:58± 1:02, P<0.001). Processing time corre­
lated with LV chamber size for MP (r=0.57, P<0.001) and 
AS (r=0.24, P=0.007). However, as shown in corresponding 
scatterplots for each method (Figure 3B), regression slopes 
were >30-fold higher for MP (0.89) compared with AS 
(0.03), reflecting a markedly higher proportionate increase in 
processing time in relation to chamber size.
Partial Voxel Segmentation
AS was also used to calculate LVM with incorporation of 
myocardial partial voxels (ASpv). Table 3 compares ASpv 
with MP and ASFV. As shown, LVM by ASpv was higher 
compared with either MP (Δ=20±10 g) or ASFV (Δ=23±6
g, P<0.001), corresponding to relative differences of 14% 
and 17%, respectively. LVM by ASpv yielded a similar 
proportion of patients (5%) meeting established criteria for 
LV hypertrophy26 compared with either MP (3%; P=0.50) or 
ASfv (4%; P=l.00). However, ASpv yielded a markedly 
lower proportion of patients (26%) meeting established cri­
teria for LV chamber remodeling27 than did MP (57%; 
P<0.001) or ASfv (56%; P<0.001).
In multivariable analysis, magnitude of difference between 
ASpv and ASfv independently correlated with larger voxel 
size (partial r=0.37, P<0.001) even after controlling for LV 
chamber volume (r=0.28, P=0.002) and LVM (r=0.19, 
P=0.03) as quantified by the standard of full voxel segmen­
tation (model r=0.64, P<0.001).
All segmentation methods demonstrated good intrareader 
and inter-reader reproducibility, although limits of agreement
Table 3. Comparison of Full and Partial Voxel-Adjusted LV Mass
were smaller for both ASfv and ASpv by AS compared with 
MP (Figure 4).
Figure 3. Processing time. A, Processing time for manual planimetry (MP) (black bar) and automated segmentation (AS) (gray bar). 
Data shown as mean±SD. B, Corresponding scatterplots for MP (left) and AS (right) relating left ventricular (LV) chamber volume 
(x-axis) to processing time (y-axis) for each method.
Validation
Each CMR segmentation method was independently com­
pared with 2 standards: (1) a clinical standard of LVM 
measured on echo and (2) an ex vivo standard of LVM as 
weighed at time of necropsy.
LVM by Echocardiography
Echo was performed within 1 day of CMR in all patients 
(97% same day); 96% of echoes (n=121) were technically 
sufficient to quantify LVM. The most common reasons for 
technically insufficient echoes (4%) were poor endocardial 
definition or off-axis imaging.
Partial Voxel
ASpv
Mean±SD
ASfv MP
Mean±SD Δ* Pk Mean±SD Δ* P*
LV mass, g 158.7±37.9 135.9±34.9 22.8±5.5 <0.001 139.1 ±35.1 19.7±10.1 <0.001
LV mass index, g∕m2 81.2±16.2 69.5±15.3 11.7±2.4 <0.001 71.1±15.1 10.1 ±5.0 <0.001
LV indicates left ventricular; AS, automated segmentation; MP, manual planimetry.
‘Difference (mean±SD) vs partial voxel-adjusted LV mass (P values adjusted for multiple comparisons).
Figure 4. Reproducibility. Bland-Altman plots demonstrating reproducibility data for each segmentation method. Data shown as 
mean±2 SD. A, provides intraobserver data, demonstrating that mean differences for all methods were small (MP: 1.1 g, automated 
segmentation [AS]FV: -0.3 g, ASpv -0.6 g), although limits of agreement were narrower for ASfv (-4.3 to 3.8 g) and ASpv (-5.6 to 
4.5 g) compared with MP (-12.1 to 14.3 g). Interobserver measurements (B) demonstrated similar findings. LV indicates left ventricular; 
CMR, cardiac magnetic resonance; MP, manual planimetry.
Figure 5A shows LVM results by each method, demon­
strating that echo yielded higher LVM than did all CMR 
segmentation methods (P<0.001). However, as shown in 
Figure 5B, mean differences between CMR and echo were 
smallest with LVMpv (Δ=20±25 g, 11±13 g∕m2) compared 
with LVMfv by either AS (Δ=43±24 g, 22± 12 g∕m2) or MP 
(Δ=40±22 g, 20+12 g∕m2) (both P<0.001).
LV Weight at Necropsy
LVM segmentation methods were also tested in a preexisting 
cohort of 10 animals (8 dogs, 2 pigs) that underwent CMR 
before euthanasia. Figure 6 shows results of each CMR 
method compared with the reference standard of ex vivo LV 
weight: LVM averaged 70± 13 g at necropsy and 69± 14 g by 
LVMpv, reflecting nonsignificant absolute and relative dif­
ferences of 1±3 g and 4±3% (P=0.54). Automated LVMfv 
was lower (63 ±14 g) and yielded significant differences 
(7±3 g, 10±6%) with ex vivo LV weight (P<0.001). MP 
paralleled automated full voxel data, as reflected by lower 
LVM (65±16 g) that differed significantly (4±5 g, 8±7%; 
P=0.049) from ex vivo results.
Discussion
This study is the first to examine partial voxel segmentation 
for automated LVM quantification. There are several key 
findings: First, among the consecutive series of post-MI 
patients studied, AS using full voxel analysis (ASfv) yielded 
similar results to manual planimetry (MP), with small albeit
statistically significant, absolute differences (3 ±9 g, 
P<0.001). Both methods yielded similar results concerning 
classification of patients with LV remodeling (P=0.73) or 
hypertrophy (P=1.00). Second, AS using partial voxel anal­
ysis (ASpv) yielded larger LVM than AS using full voxel 
analysis (Δ=23±6 g) or MP (Δ=20±10 g; both P<0.001). 
Magnitude of difference between ASpv and ASfv indepen­
dently correlated with larger voxel size (partial r=0.37, 
P<0.001) even after controlling for LV chamber volume 
(r=0.28, P=0.002) and LVM (r=0.19, P=0.03) (model 
r=0.64, P<0.001). Third, ASpv yielded better agreement 
with the clinical standard of LVM by echo and smaller 
differences with LV weight at necropsy.
Regarding necropsy data, automated segmentation was 
applied to a preexisting CMR dataset in which actual LV 
weight was verified ex vivo. Results demonstrated that partial 
voxel segmentation yielded nonsignificant differences with 
necropsy-evidenced LVM (1±3 g, P=0.3), whereas full 
voxel yielded small but significant differences when either 
AS (6±3 g, P<0.001) or MP (4±5 g, P=0.02) were used. 
This finding is consistent with prior cine-CMR (SSFP) 
studies that have reported small mean differences between 
CMR and necropsy LVM but have noted variability ranging 
from —0.8±2.6 to 0.2±8.4 g with MP and —10.6±7.1 to 
4.2±7.1 g with AS.6·28·29 Although the reasons for variable 
differences in CMR and necropsy results are not certain, this 
may relate to animal and study specific differences in spatial 
resolution, image quality, or interval between imaging and 
necropsy with resultant postmortem changes in LVM.
Figure 5. Comparison to echocardiography. A, Mean left ventricular mass (LVM) by each cardiac magnetic resonance (CMR) segmen­
tation method (gray bars) compared with echo (black bar) among patient cohort (n=121). B, Mean LVM difference between each CMR 
method and echo, demonstrating smaller differences with automated segmentation (AS)pv as compared with ASfv or manual planimetry 
(P<0.001; all probability values adjusted for multiple comparisons).
To further test CMR segmentation versus an independent 
clinical reference, patient results were compared with LVM 
as quantified by echo. Findings demonstrated that whereas all 
CMR methods yielded lower LVM than echo, partial voxel 
analysis yielded smaller mean differences (20 ±25 g, 11±13 
g∕m2, P<0.001) than did AS full voxel (43±24 g, 22±12
g∕m2) or MP (40±22 g, 20±12 g∕m2). Prior comparative 
studies have used MP and also reported lower LVM by 
CMR,30-32 although variance has been larger than in our 
study, as evidenced by mean differences of 37 ±39 g∕m2 in 
cohorts with valvular heart disease and 58±63 g (data 
reported unindexed) in heart transplant patients.31·33
Figure 6. Comparison to necropsy. Left ventricular (LV) mass by each cardiac magnetic resonance segmentation method (gray bars) 
compared with necropsy-derived LV weight (black bar) among animal cohort (n=10). Only automated segmentation (AS)pv yielded 
nonsignificant differences with LV weight at necropsy (all probability values adjusted for multiple comparisons).
Our data shed new light on prior comparative studies, 
which have commonly attributed LVM differences between 
modalities to echo-specific factors. Certainly, it is important 
to recognize that echo-based calculations employ geometric 
assumptions whereas CMR quantifies LVM based on actual 
planimetry of myocardial borders: Both off axis imaging and 
image quality can affect echo measurements, whereas CMR 
provides high resolution imaging with great precision for 
detecting small differences in LVM.33 However, prior papers 
have demonstrated systematically lower LVM by CMR 
versus echo,30-32 suggesting intrinsic biases not fully ex­
plained by echo alone in context of several studies showing 
unbiased estimation of echo-derived LVM versus necropsy- 
verified LV weight.18,19,21
Our results suggest that previously reported differences 
between CMR and echo may be partially attributable to the 
approach used for CMR segmentation, with agreement im­
proved through quantification of myocardial partial voxel 
content. Although reasons for improved agreement between 
echo and partial voxel CMR are uncertain, we speculate that 
this may be due to the fact that echo-formulas use linear 
measurements to calculate LVM based on models derived 
from actual LV weight (ie, trabeculae inclusive) at nec­
ropsy,18,19,21 an approach that can yield error on an individual 
patient basis but provide generally accurate LVM when 
measured for overall populations. Partial voxel CMR calcu­
lates LVM without geometric assumptions while accounting 
for detailed components of LV myocardium (ie, trabeculae) 
that can be difficult to trace manually but contribute to overall 
LV weight, resulting in higher LVM values for individual 
patients and across populations. These issues may explain 
improved agreement between partial voxel CMR and echo, as 
well as residual differences between modalities. Consistent 
with this, our group’s prior research has demonstrated that 
failure to segment trabecular volume on CMR yields in­
creased discrepancy with linear echo formulas for LVM.8 As 
multimodality imaging is increasingly being used to guide 
patient care, the ability of partial voxel CMR segmentation to 
yield improved agreement with echo-derived LVM is of 
substantial clinical importance.
Beyond partial voxel segmentation, a novel feature of the 
AS algorithm tested in this study is that no geometric 
assumptions regarding endocardial shape are used.13 This 
differs from several prior AS algorithms, which have used 
shape-based constraints regarding LV border geometry.34-38 
In contradistinction, the algorithm tested in this study relies 
on only one fundamental assumption—LV blood is enclosed 
by LV myocardium. On this basis, AS is performed using an 
automated effusion-threshold-based approach that relies on 
intrinsic differences in signal intensity between blood and 
myocardium rather than shape-based algorithmic constraints. 
This feature is complementary to partial voxel segmentation, 
in that it enables LV segmentation independent of 
remodeling-associated changes in LV contours. Moreover, 
the current algorithm segmented all cases in less than 1 
minute, a considerable time saving compared with MP. 
Whereas few prior studies have reported actual processing 
times, we note that mean processing time for AS in the
current study (0:21 ±0:04) was far lower than that reported 
for prior shape-based AS algorithms (5:00±0:18 minutes).29
Concerning clinical performance, study results demon­
strate the utility of geometry-independent effusion-threshold 
segmentation. Among the consecutive series of 126 patients 
tested, AS was successful in all cases and required minimal 
user corrections. Absolute differences between ASfv and MP 
were significant but small (Δ=3±9 g, P<0.001), resulting in 
nonsignificant differences when established CMR criteria for 
LV hypertrophy and remodeling were applied. The relative 
agreement between MP and ASfv can be explained at least in 
part by the similarities between the two techniques. When 
performing MP, an operator visually discerns LV myocardi­
um from blood, based on shape or signal intensity,4,7,8,16 with 
regions of similar signal intensity partitioned together. With 
this approach, voxels that contain any amount of fractional 
blood content (and thus exhibit higher signal intensity than 
the adjacent myocardium) are included in blood volume, even 
though they may also include fractional myocardial content. 
Similarly, ASfv uses an algorithm that simply counts the 
number of voxels with any fractional blood content; thus, it 
labels regions that are inherently brighter than LV myocar­
dium (due to fractional blood content) as blood, even though 
they may also contain fractional myocardial content. In 
contrast, partial voxel segmentation allows fractional quanti­
fications of both blood and myocardium within each voxel 
region. Thus, ASpv would be expected to be of incremental 
utility when increased voxel size results in juxtaposition of 
myocardium and blood within a single voxel—a phenomenon 
that is not accounted for by MP or full voxel analysis. 
Consistent with this, our results demonstrate that differences 
between full and partial voxel segmentation correlate with 
larger voxel size (r=0.37, P<0.001) even after controlling 
for LV cavity size and total LVM.
Several limitations should be recognized. First, clinical 
performance of CMR segmentation was tested among pa­
tients in a post-MI registry, the majority (81%) of whom were 
male. Although this enabled us to test segmentation among 
patients with Mi-associated LV remodeling, further study is 
needed to evaluate partial voxel segmentation in broad 
population-based cohorts. Second, although results demon­
strate that partial voxel segmentation yields better agreement 
with independent standards of echo and necropsy quantified 
LVM, clinical outcomes data were not obtained and the 
predictive value of partial versus full voxel CMR segmenta­
tion results is not known. Finally, although geometry- 
independent partial voxel segmentation was shown to per­
form robustly, minimal user interaction is still required to 
identify the actual LV slices to be segmented.
In summary, this study demonstrates that partial voxel 
automated segmentation is a promising improvement for 
LVM quantification. Future research is necessary to test 
whether partial voxel-adjusted LVM provides incremental 
utility versus full voxel assessment for clinical prognostic 
assessment.
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CLINICAL PERSPECTIVE
Left ventricular mass (LVM) is widely used to guide clinical decision-making and prognostic assessment. Cardiac magnetic 
resonance (CMR) is well suited to assess LVM because it provides high-resolution tomographic imaging that enables 
volumetric quantification without geometric assumptions. CMR typically quantifies LVM by manual planimetry (MP) of 
LV chamber contours: This approach is widely used in clinical practice but can be time-consuming, challenging with 
respect to planimetry of irregularly contoured trabeculae, and limited in its ability to account for myocardial partial 
voxels—myocardium admixed with blood in a single voxel. Recent advances in automated segmentation (AS) have 
enabled quantification of partial voxel components. This study tested a novel AS algorithm that can quantify LVM while 
accounting for myocardial partial voxels. Among laboratory animals undergoing CMR before euthanasia, LVM quantified 
using AS-based partial voxel segmentation (ASpv) yielded nonsignificant differences with LV weight at necropsy, whereas 
both conventional AS and MP yielded small but significant underestimations. Among patients undergoing CMR within 1 
day of echocardiography, ASpv yielded significantly smaller differences with echocardiography-quantified LVM than did 
either conventional AS or MP. AS was successful in all patients, required minimal manual adjustments (1.0 ±1.6 per 
examination), and yielded a 12-fold reduction in processing time versus MP (0:21 ±0:04 versus 4:18±l:02 minutes; 
P<0.001). These results support use of automated partial voxel segmentation for quantification of LVM, demonstrating 
that this method markedly reduces CMR processing time among clinical patients while yielding improved agreement with 
independent references of both echocardiography and necropsy-verified LVM.
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